Literature DB >> 15932504

Palsy of the rear limbs in Mycobacterium lepraemurium-infected mice results from bone damage and not from nerve involvement.

O Rojas-Espinosa1, E Becerril-Villanueva, K Wek-Rodríguez, P Arce-Paredes, E Reyes-Maldonado.   

Abstract

A small but relatively constant proportion (3-5%) of mice chronically infected with Mycobacterium lepraemurium (MLM) develops bilateral paralysis of the rear limbs. The aim of the study was to investigate whether or not the bilateral leg palsy results from nerve involvement. Direct bacterial nerve infection or acute/delayed inflammation might possibly affect the nerves. Therefore, palsied animals were investigated for the presence of: (a) histopathological changes in the leg tissues including nerves, bones and annexes, and (b) serum antibodies to M. lepraemurium and M. leprae lipids, including phenolic glycolipid I from M. leprae. Histopathological study of the palsied legs revealed that the paralysis was not the result of direct involvement of the limb nerves, as neither bacilli nor inflammatory cells were observed in the nerve branches studied. Antibodies to brain lipids and cardiolipin were not detected in the serum of the palsied animals, thus ruling out an immune response to self-lipids as the basis for the paralysis. Although high levels of antibodies to MLM lipids were detected in the serum of palsied animals they were not related to limb paralysis, as the nerves of the palsied legs showed no evidence of inflammatory damage. In fact, nerves showed no evidence of damage. Paralysis resulted from severe damage of the leg bones. Within the bones the bone marrow became replaced by extended bacilli-laden granulomas that frequently eroded the bone wall, altering the normal architecture of the bone and its annexes, namely muscle, tendons and connective tissue. Although this study rules out definitively the infectious or inflammatory damage of nerves in murine leprosy, it opens a new avenue of research into the factors that participate in the involvement or the sparing of nerves in human and murine leprosy, respectively.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15932504      PMCID: PMC1809397          DOI: 10.1111/j.1365-2249.2005.02776.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

Review 1.  Leprosy lipid provides the key to Schwann cell entry.

Authors:  D B Young
Journal:  Trends Microbiol       Date:  2001-02       Impact factor: 17.079

2.  A simple method for the isolation and purification of total lipides from animal tissues.

Authors:  J FOLCH; M LEES; G H SLOANE STANLEY
Journal:  J Biol Chem       Date:  1957-05       Impact factor: 5.157

3.  Recognition of phenolic glycolipid-I (Mycobacterium leprae) and sulfolipid-I (M. tuberculosis) by serum from Mexican patients with leprosy or tuberculosis.

Authors:  O Rojas-Espinosa; J Luna-Herrera; P Arce-Paredes
Journal:  Int J Tuberc Lung Dis       Date:  1999-12       Impact factor: 2.373

4.  Do antibodies to phospholipid antigens play any role in murine leprosy?

Authors:  O Rojas-Espinosa; K Wek Rodriguez; J A Vargas Hernandez; P Arce Paredes
Journal:  Int J Lepr Other Mycobact Dis       Date:  1999-12

5.  Purification of phenolic glycolipid I from armadillo and human sources.

Authors:  S W Hunter; C Stewart; P J Brennan
Journal:  Int J Lepr Other Mycobact Dis       Date:  1985-09

6.  Role of the cell wall phenolic glycolipid-1 in the peripheral nerve predilection of Mycobacterium leprae.

Authors:  V Ng; G Zanazzi; R Timpl; J F Talts; J L Salzer; P J Brennan; A Rambukkana
Journal:  Cell       Date:  2000-10-27       Impact factor: 41.582

7.  Expression of Toll-like receptor 2 on human Schwann cells: a mechanism of nerve damage in leprosy.

Authors:  Rosane B Oliveira; Maria T Ochoa; Peter A Sieling; Thomas H Rea; Anura Rambukkana; Euzenir N Sarno; Robert L Modlin
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

8.  Electron microscope appearance of lepromatous footpads of nude mice [corrected].

Authors:  Charles K Job; Grgory T McCormick; David M Scollard; Richard W Truman
Journal:  Int J Lepr Other Mycobact Dis       Date:  2003-09

9.  Intracellular multiplication of leprosy-derived mycobacteria in Schwann cells of dorsal root ganglion cultures.

Authors:  R Mukherjee; N H Antia
Journal:  J Clin Microbiol       Date:  1985-05       Impact factor: 5.948

10.  Antibodies to diverse lipids in the serum of patients with clinically cured leprosy and tuberculosis.

Authors:  O Rojas-Espinosa; R Arenas; P Arce-Parades; G Miranda-Contreras
Journal:  Acta Leprol       Date:  2003
View more
  4 in total

1.  Successive Intramuscular Boosting with IFN-Alpha Protects Mycobacterium bovis BCG-Vaccinated Mice against M. lepraemurium Infection.

Authors:  G G Guerrero; J Rangel-Moreno; S Islas-Trujillo; Ó Rojas-Espinosa
Journal:  Biomed Res Int       Date:  2015-09-21       Impact factor: 3.411

2.  Single nucleotide polymorphism analysis of European archaeological M. leprae DNA.

Authors:  Claire L Watson; Diana N J Lockwood
Journal:  PLoS One       Date:  2009-10-22       Impact factor: 3.240

3.  Downregulation of PHEX in multibacillary leprosy patients: observational cross-sectional study.

Authors:  Sandra R Boiça Silva; Ximena Illarramendi; Antonio J Tempone; Pedro H L Silva; José A C Nery; Alexandra M V Monteiro; Maria Cristina V Pessolani; Edson Boasquevisque; Euzenir N Sarno; Geraldo M B Pereira; Danuza Esquenazi
Journal:  J Transl Med       Date:  2015-09-11       Impact factor: 5.531

4.  Chronic infection with Mycobacterium lepraemurium induces alterations in the hippocampus associated with memory loss.

Authors:  Enrique Becerril-Villanueva; María Dolores Ponce-Regalado; Gilberto Pérez-Sánchez; Alberto Salazar-Juárez; Rodrigo Arreola; María Elizbeth Álvarez-Sánchez; Mario Juárez-Ortega; Ramcés Falfán-Valencia; Rogelio Hernández-Pando; Jorge Morales-Montor; Lenin Pavón; Oscar Rojas-Espinosa
Journal:  Sci Rep       Date:  2018-06-13       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.